Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma

Tekijä Sabado, Rachel L, Pavlick, Anna, Gnjatic, Sacha, Cruz, Crystal, Vengco, Isabelita, Hasan, Farah, Darvishian, Farbod, Chiriboga, Luis, Holman, Rose Marie, Escalon, Juliet, Muren, Caroline, Escano, Crystal, Yepes, Ethel, Sharpe, Dunbar, Adams, Sylvia, Ott, Patrick, Jungbluth, Achim, Pan, Linda, Venhaus, Ralph, Bhardwaj, Nina
Julkaistu 2013

Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High Risk Melanoma

Tekijä Sabado, Rachel Lubong, Pavlick, Anna, Gnjatic, Sacha, Cruz, Crystal M., Vengco, Isabelita, Hasan, Farah, Spadaccia, Meredith, Darvishian, Farbod, Chiriboga, Luis, Holman, Rose Marie, Escalon, Juliet, Muren, Caroline, Escano, Crystal, Yepes, Ethel, Sharpe, Dunbar, Vasilakos, John P., Rolnitzsky, Linda, Goldberg, Judith, Mandeli, John, Adams, Sylvia, Jungbluth, Achim, Pan, Linda, Venhaus, Ralph, Ott, Patrick A., Bhardwaj, Nina
Julkaisussa Cancer Immunol Res (2015)